stockrowHCA Healthcare, Inc.
HCA Healthcare Medical Care Facilities
HCA Healthcare, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $75.6 billion, up 7.08% from fiscal 2024.
- Revenue
- +3.59%
- EPS
- +23.8%
- Free cash flow
- −0.77%
- Total debt
- +13.4%
Quarter to September 2026, against a year earlier
Follow HCA
Alert me
HCA Healthcare, Inc. (HCA) P/B ratio
HCA Healthcare, Inc. has no meaningful P/B ratio: its trailing twelve-month book value is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 359× (June 2023) — the current reading is the lowest in ten years.
P/B ratio, daily
Embed this chart
Annual newest first
| Period | P/B ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 140× | 97.67% |
| FY2023 | 70.8× | — |
| FY2022 | 0.0× | — |
| FY2021 | 55.8× | 190.00% |
| FY2020 | 19.2× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | P/B ratio | Change |
|---|---|---|
| Sep 2026 | 0.0× | — |
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| 43 more quarters | Free account |
Against its own ten years
P/B ratio against peers
| Company | P/B ratio |
|---|---|
| HCA HCA Healthcare, Inc. | n/m |
| DVA DaVita Inc. compare | n/m |
| FMS Fresenius Medical Care AG & Co. KGaA compare | 0.8× |
| THC Tenet Healthcare Corporation compare | 3.1× |
| EHC Encompass Health Corporation compare | 3.9× |
| ENSG The Ensign Group, Inc. compare | 4.1× |
| PACS PACS Group, Inc. compare | 6.5× |
| CHE Chemed Corporation compare | 8.0× |
| UHS Universal Health Services, Inc. compare | 161× |
| Medical Care Facilities industry median | 3.1× |
| Healthcare sector median | 2.3× |
| Market median | 1.7× |
What P/B ratio is
Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.
Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))
More on HCA
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement